← Open Payments lookup

LUZELLE CABUNTALA: Open Payments

NPI 1235966177 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,557 in 99 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $252 · 2025 $2,557

Food & beverage: $2,480Education: $77
CompanyPaymentsAmount
Janssen Biotech, Inc.18$575
ABBVIE INC.14$334
Salix Pharmaceuticals, a division of Bausch Health US, LLC11$277
Phathom Pharmaceuticals, Inc.9$227
GENZYME CORPORATION15$220
Gilead Sciences, Inc.9$219
Novo Nordisk Inc4$162
Aimmune Therapeutics, Inc.1$110
Intra-Sana Laboratories4$97
Lilly USA, LLC2$54

Products named: TREMFYA, XIFAXAN, DUPIXENT, VOQUEZNA, SKYRIZI, Wegovy, RINVOQ, ZENPEP.

Industry payments across NV — which companies pay providers there.